(Basel) 10, 31
On April 30, 2026, the FDA announced a formal proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List - the regulatory mechanism that governs which bulk substances large-scale 503B outsourcing facilities may use in compounding
But when we first joined with you guys in 2018 I was going through a kind of a business transition, a personal life transition as well
Clinical studies have shown that this higher dose leads to greater weight loss compared to the doses used for diabetes management
The fact that supplements are positioned as GLP-1 boosters doesnt change their fundamental role in a healthy dietit just adds misleading context to a legitimately beneficial practice
Your healthcare provider may sometimes prescribe nonGLP-1 peptides such as CJC-1295, Ipamorelin, Tesamorelin, AOD-9604, or MOTS-c off-label to help boost metabolism, reduce stubborn fat, and support muscle growth Always use a peptide prescribed by your licensed healthcare provider and avoid unregulated sources to ensure safety and effectiveness